Pavmed Inc Stock Alpha and Beta Analysis
| PAVM Stock | USD 0.94 0.04 4.44% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as PAVmed Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in PAVmed over a specified time horizon. Remember, high PAVmed's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to PAVmed's market risk premium analysis include:
Beta (1.41) | Alpha 0.53 | Risk 8.66 | Sharpe Ratio 0.0442 | Expected Return 0.38 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
PAVmed |
PAVmed Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. PAVmed market risk premium is the additional return an investor will receive from holding PAVmed long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in PAVmed. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate PAVmed's performance over market.| α | 0.53 | β | -1.41 |
PAVmed expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of PAVmed's Buy-and-hold return. Our buy-and-hold chart shows how PAVmed performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.PAVmed Market Price Analysis
Market price analysis indicators help investors to evaluate how PAVmed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PAVmed shares will generate the highest return on investment. By understating and applying PAVmed stock market price indicators, traders can identify PAVmed position entry and exit signals to maximize returns.
PAVmed Return and Market Media
The median price of PAVmed for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 1.1 with a coefficient of variation of 19.83. The daily time series for the period is distributed with a sample standard deviation of 0.23, arithmetic mean of 1.17, and mean deviation of 0.17. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements | 09/16/2024 |
2 | Acquisition by Agrawal Sundeep of 205000 shares of PAVmed at 1.63 subject to Rule 16b-3 | 09/19/2024 |
3 | Discretionary transaction by Sirovich Matthew of tradable shares of PAVmed subject to Rule 16b-3 | 10/04/2024 |
4 | Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit | 10/09/2024 |
5 | Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test | 10/15/2024 |
6 | Acquisition by Agrawal Sundeep of 50000 shares of PAVmed at 1.04 subject to Rule 16b-3 | 10/21/2024 |
7 | Acquisition by Battleman David S. of 200000 shares of PAVmed at 1.0 subject to Rule 16b-3 | 10/24/2024 |
8 | Mesa Labs Lags Q2 Earnings and Revenue Estimates | 11/07/2024 |
9 | PAVmed Provides Business Update and Third Quarter 2024 Financial Results | 11/14/2024 |
10 | Earnings call PAVmed reports strategic shifts and Q3 financials | 11/15/2024 |
11 | Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health Services Forum | 11/18/2024 |
About PAVmed Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including PAVmed or other stocks. Alpha measures the amount that position in PAVmed Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2023 | 2024 (projected) | Dividend Yield | 3.31E-4 | 2.98E-4 | 2.65E-4 | Price To Sales Ratio | 381.38 | 12.15 | 11.54 |
PAVmed Upcoming Company Events
As portrayed in its financial statements, the presentation of PAVmed's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PAVmed's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of PAVmed's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of PAVmed. Please utilize our Beneish M Score to check the likelihood of PAVmed's management manipulating its earnings.
| 12th of March 2024 Upcoming Quarterly Report | View | |
| 21st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with PAVmed
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out PAVmed Backtesting, PAVmed Valuation, PAVmed Correlation, PAVmed Hype Analysis, PAVmed Volatility, PAVmed History and analyze PAVmed Performance. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
PAVmed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.